Dr. Robert Bisbee , MD
Internal Medicine • Lubbock, TX
808 Joliet Ave Unit 120
Lubbock, TX 794151148
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Robert Bisbee is listed in NPPES under Internal Medicine.
-
NPI assigned on May 23, 2005; this date does not establish years in practice.
-
Published CMS data list 767 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 255 service units.
- G2211 — Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 138 service units.
- 99213 — Established patient outpatient office visit: 104 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 11 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 4,552 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Atorvastatin Calcium — 242 prescription fills, including refills.
- Levothyroxine Sodium — 231 prescription fills, including refills.
- Lisinopril — 187 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 97 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Medicare Part B services among clinicians listed under Internal Medicine in Lubbock, TX (2024, 72 clinicians with data). Median for this group: 718. Middle half: 318 to 1,399.
Close to the middle for Medicare Part B services among clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: 645. Middle half: 277 to 1,322.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 657 in 2020 to 767 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
808 Joliet Ave Unit 120
Lubbock, TX 794151148
CMS Doctors and Clinicians lists 1 group name: Texas Tech University Health Sciences Center Lubbock. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Texas Tech University Health Science Center School Of Medicine
1994
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
219 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $67,353 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $50,792 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
9,483 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$474,687 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $342.58 across 16 records.
By nature of payment
- Food and Beverage: $342.58 across 16 records.
Reporting-company totals (3 largest of 11)
- Regeneron Pharmaceuticals, Inc.: $87.03 across 4 records.
- Melinta Therapeutics, LLC: $36.16 across 2 records.
- Mallinckrodt Hospital Products Inc.: $35.67 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
32 years (graduated 1994)
CMS Doctors and Clinicians data list 1994 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Bisbee has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Bisbee as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Lubbock and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Close to the middle for clinicians listed under Internal Medicine in Lubbock, TX (2024, 72 clinicians with data). Median for this group: 718. Middle half: 318 to 1,399.
Close to the middle for clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: 645. Middle half: 277 to 1,322.
Medicare-allowed amount
Close to the middle for clinicians listed under Internal Medicine in Lubbock, TX (2024, 72 clinicians with data). Median for this group: $66,297. Middle half: $24,645 to $131,730.
Close to the middle for clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: $61,221. Middle half: $27,420 to $115,826.
Paid by Medicare
Close to the middle for clinicians listed under Internal Medicine in Lubbock, TX (2024, 72 clinicians with data). Median for this group: $51,002. Middle half: $19,816 to $103,597.
Close to the middle for clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: $47,501. Middle half: $20,446 to $90,051.
Medicare Part D prescriptions
More Part D prescriptions than 80% of clinicians listed under Internal Medicine in Lubbock, TX (2024, 85 clinicians with data). Median for this group: 345. Middle half: 111 to 2,408.
More Part D prescriptions than 70% of clinicians listed under Internal Medicine in Texas (2024, 5,674 clinicians with data). Median for this group: 828. Middle half: 121 to 4,824.
Part D drug cost
A higher Part D drug cost than 85% of clinicians listed under Internal Medicine in Lubbock, TX (2024, 85 clinicians with data). Median for this group: $38,932. Middle half: $7,887 to $332,818.
A higher Part D drug cost than 75% of clinicians listed under Internal Medicine in Texas (2024, 5,674 clinicians with data). Median for this group: $64,859. Middle half: $4,211 to $436,775.
116 active clinicians are listed under Internal Medicine with a practice address in Lubbock, TX (9,191 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Lubbock
6% of these 116 clinicians have the CMS telehealth indicator.
64.7% of these 116 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 17% from 657 in 2020 to 767 in 2024.
- 2020: 657
- 2021: 686
- 2022: 545
- 2023: 1,005
- 2024: 767
-
Medicare-allowed amount
Medicare-allowed amount increased 15% from $58,343 in 2020 to $67,353 in 2024.
- 2020: $58,343
- 2021: $78,123
- 2022: $65,750
- 2023: $74,496
- 2024: $67,353
-
Paid by Medicare
Paid by Medicare increased 19% from $42,647 in 2020 to $50,792 in 2024.
- 2020: $42,647
- 2021: $59,369
- 2022: $48,923
- 2023: $57,966
- 2024: $50,792
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 4,420 in 2020 and 4,552 in 2024.
- 2020: 4,420
- 2021: 4,599
- 2022: 5,125
- 2023: 4,709
- 2024: 4,552
-
30-day fills
30-day fills increased 20% from 7,873 in 2020 to 9,483 in 2024.
- 2020: 7,873
- 2021: 8,303
- 2022: 9,631
- 2023: 9,547
- 2024: 9,483
-
Part D drug cost
Part D drug cost increased 28% from $371,653 in 2020 to $474,687 in 2024.
- 2020: $371,653
- 2021: $406,350
- 2022: $524,285
- 2023: $552,701
- 2024: $474,687
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $50.67 in 2023 to $342.58 in 2025.
- 2023: $50.67
- 2024: $335.35
- 2025: $342.58
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 16 records totaling $342.58.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Mallinckrodt Hospital Products Inc. |
Food and Beverage
In-kind items and services
|
ACTHAR | General | $35.67 |
| Soleno Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
VYKAT XR | General | $33.08 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $31.75 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $28.74 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $26.97 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
GATTEX | General | $23.08 |
| Melinta Therapeutics, LLC |
Food and Beverage
In-kind items and services
|
Rezzayo | General | $18.52 |
| Melinta Therapeutics, LLC |
Food and Beverage
In-kind items and services
|
Rezzayo | General | $17.64 |
| Inogen, Inc. |
Food and Beverage
Cash or cash equivalent
|
INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH | General | $17.29 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $17.27 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
— | General | $16.94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JASCAYD | General | $16.71 |
| Inogen, Inc. |
Food and Beverage
Cash or cash equivalent
|
INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH | General | $15.98 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
— | General | $14.88 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $14.05 |
| Phathom Pharmaceuticals, Inc. |
Food and Beverage
Cash or cash equivalent
|
VOQUEZNA | General | $14.01 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
255 | 159 | $220.00 | $128.69 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
138 | 113 | $32.00 | $16.40 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
104 | 88 | $155.00 | $89.26 |
|
99457
Management using the results of remote vital sign monitoring per calendar month, first 20 minutes
|
90 | 11 | $110.00 | $49.41 |
|
G0439
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
|
67 | 67 | $286.00 | $133.52 |
|
87804
Detection test by immunoassay with direct visual observation for influenza virus
|
36 | 17 | $61.00 | $15.50 |
|
99495
Transitional care management services for problem of at least moderate complexity
|
21 | 20 | $353.00 | $209.19 |
|
87426
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus
|
18 | 18 | $100.00 | $33.19 |
|
87880
Detection test by immunoassay with direct visual observation for streptococcus, group a (strep)
|
13 | 13 | $34.00 | $15.13 |
|
G0009
Administration of pneumococcal vaccine
|
13 | 13 | $46.00 | $31.03 |
|
90677
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use
|
12 | 12 | $595.00 | $287.49 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 242 | 19,015 | $2,117.22 | 70 |
| Levothyroxine Sodium | Levothyroxine Sodium | 231 | 16,216 | $2,217.99 | 53 |
| Lisinopril | Lisinopril | 187 | 15,379 | $931.96 | 58 |
| Pioglitazone Hcl | Pioglitazone Hcl | 162 | 12,898 | $1,678.23 | 45 |
| Metformin Hcl | Metformin Hcl | 158 | 13,563 | $1,067.52 | 47 |
| Amlodipine Besylate | Amlodipine Besylate | 154 | 11,580 | $592.24 | 45 |
| Gabapentin | Gabapentin | 144 | 8,950 | $3,353.24 | 38 |
| Tramadol Hcl | Tramadol Hcl | 123 | 3,117 | $1,874.73 | 26 |
| Duloxetine Hcl | Duloxetine Hcl | 107 | 7,330 | $3,031.05 | 31 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 100 | 7,410 | $968.90 | 29 |
| Losartan Potassium | Losartan Potassium | 86 | 6,659 | $538.17 | 24 |
| Jardiance | Empagliflozin | 86 | 4,990 | $95,717.60 | 21 |
| Zolpidem Tartrate | Zolpidem Tartrate | 84 | 3,420 | $270.14 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 84 | 2,440 | $1,977.68 | 21 |
| Pantoprazole Sodium | Pantoprazole Sodium | 83 | 5,470 | $1,226.52 | 29 |
| Tamsulosin Hcl | Tamsulosin Hcl | 78 | 6,030 | $1,191.73 | 23 |
| Pravastatin Sodium | Pravastatin Sodium | 75 | 6,590 | $701.01 | 23 |
| Mounjaro | Tirzepatide | 72 | 2,216 | $79,400.18 | 13 |
| Omeprazole | Omeprazole | 66 | 5,656 | $1,052.72 | 19 |
| Metoprolol Succinate | Metoprolol Succinate | 65 | 4,263 | $403.52 | 17 |
| Alendronate Sodium | Alendronate Sodium | 63 | 3,111 | $301.64 | 14 |
| Trazodone Hcl | Trazodone Hcl | 63 | 3,210 | $187.57 | — |
| Ozempic | Semaglutide | 62 | 2,028 | $70,116.50 | — |
| Fluoxetine Hcl | Fluoxetine Hcl | 61 | 3,762 | $631.36 | 20 |
| Metoprolol Tartrate | Metoprolol Tartrate | 60 | 4,850 | $323.64 | 17 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - INTERNAL MEDICINE
I20100107000094
TX
6204977663
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Texas Tech University Health Sciences Center Lubbock
3601 4th St, Lubbock, TX 794309406
Phone: 8067437337
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
NPI status registered as active in NPPES database
Registered at 808 JOLIET AVE UNIT 120, LUBBOCK, TX 794151148 (Tel: 8067610540)
Registered at 5219 CITY BANK PKWY STE 214, LUBBOCK, TX 794073537 (Tel: 8067810360)
Recorded as ROBERT BISBEE, MD
Internal Medicine (license number reported to NPPES: TX J8461)
NPI status registered as active in NPPES database
Registered at 113 WALNUT ST, IDALOU, TX 793294003 (Tel: 8068922537)
Registered at 5219 CITY BANK PKWY, STE 35, LUBBOCK, TX 794073545 (Tel: 8067852045)
Recorded as ROBERT BISBEE, MD
Internal Medicine (license number reported to NPPES: TX J8461)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine Providers in Lubbock
- Dr. Ibidunni Ukegbu, MD
- Dr. Miriam Paz Sierra, MD
- Dr. Stephen Tanner, MD
- Dr. Harvey De Nieva, MD
- Dr. Michael Mcpherson, MD
- Dr. Ashref Mohamed, MD
Mailing Address
5219 City Bank Pkwy Ste 214
Lubbock, TX 794073537
Phone: 8067810360